Pursuing paradoxical proconvulsant prophylaxis for epileptogenesis
Authors:
Open Access
Abstract
Summary: There are essentially two potential treatment options for any acquired disorder: symptomatic or prophylactic. For acquired epilepsies that follow a variety of different brain insults, there remains a complete lack of prophylactic treatment options, whereas at the same time these epilepsies are notoriously resistant, once they have emerged, to symptomatic treatments with antiepileptic drugs. The development of prophylactic strategies is logistically challenging, both for basic researchers and clinicians. Nevertheless, cannabinoid‐targeting drugs provide a very interesting example of a system within the central nervous system (CNS) that can have very different acute and long‐term effects on hyperexcitability and seizures. In this review, we outline research on cannabinoids suggesting that although cannabinoid antagonists are acutely proconvulsant, they may have beneficial effects on long‐term hyperexcitability following brain insults of multiple etiologies, making them promising candidates for further investigation as prophylactics against acquired epilepsy. We then discuss some of the implications of this finding on future attempts at prophylactic treatments, specifically, the very short window within which prevention may be possible, the possibility that traditional anticonvulsants may interfere with prophylactic strategies, and the importance of moving beyond anticonvulsants—even to proconvulsants—to find the ideal preventative strategy for acquired epilepsy.Keywords
This publication has 106 references indexed in Scilit:
- Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat modelEpilepsy Research, 2009
- GPR55: a new member of the cannabinoid receptor clan?British Journal of Pharmacology, 2007
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsyNeuroscience, 2007
- Endocannabinoids block status epilepticus in cultured hippocampal neuronsEuropean Journal of Pharmacology, 2007
- Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsyNeuroscience Letters, 2007
- The Endocannabinoid System Controls Key Epileptogenic Circuits in the HippocampusNeuron, 2006
- Experimental febrile seizures are precipitated by a hyperthermia-induced respiratory alkalosisNature Medicine, 2006
- Endocannabinoids potently protect the newborn brain against AMPA‐kainate receptor‐mediated excitotoxic damageBritish Journal of Pharmacology, 2006
- Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cellsNature Neuroscience, 2006